USA, April 23, 2024 – Vantage MedTech, a pioneer in medical technology design and manufacturing, appoints Jim Bartel as Chief Executive Officer. Bartel’s extensive background in medical device leadership is set to drive Vantage’s strategic expansions and enhance its market leadership.
With over two decades of experience in medical device and contract manufacturing sectors, Jim Bartel has successfully led teams across marketing, business development, and sales. His recent roles include CEO of Waltek, Inc., and President of Spectralytics, Inc., where he harnessed his expertise in manufacturing to serve the medical industry robustly.
“Vantage has been on an exciting growth journey, and I’m grateful for the opportunity to serve as CEO,” Bartel commented. “Our dedicated team of over 150 medical device engineers is committed to partnering with innovators from concept to realization, setting Vantage apart as a leader in medical technology advancements.”
Supported by Ampersand Capital Partners, a Boston-based private equity firm, Vantage is poised for further expansion. Trevor Wahlbrink, Partner at Ampersand, remarked, “Jim’s exceptional leadership qualities and profound understanding of the medical device sector’s contract services will be invaluable to Vantage’s growth strategy.”
About Vantage MedTech: Located in Moonachie, New Jersey, and Lenexa, Kansas, Vantage MedTech offers end-to-end design and manufacturing services tailored to the medical technology sector. From feasibility support and product development to clinical manufacturing and after-market services, Vantage MedTech aids every phase of product life cycle. Leveraging proprietary Advantage Platforms®, the company expedites product development and accommodates everything from small clinical builds to full-scale product launches, making it a crucial partner for both MedTech startups and established medical device firms.
Also Read : Why Workplace Happiness Matters Now More Than Ever
